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Abstract
The study measured the accuracy of the Italian version of the Mood Disorder Questionnaire
(MDQ) as a screening instrument for bipolar disorders in a psychiatric setting.
Methods: 154 consecutive subjects attending the Division of Psychiatry of the University of
Cagliari (Italy), were screened for bipolar disorders using the Italian translation of the MDQ, and
diagnostically interviewed with the Structured Clinical Interview for DSM-IV Axis I Disorders
(SCID) by physicians.
Results: On the basis of the SCID: 51 (33.1%) received a diagnosis of bipolar or schizoaffective
bipolar type disorders, 63 (40.9%) were diagnosed as having at least one psychiatric disorder in Axis
I (other than bipolar or schizoaffective bipolar type disorders), whilst 40 (25.9%) were unaffected
by any type of psychiatric disorder. MDQ showed a good accuracy for bipolar or schizoaffective
bipolar type disorders: the cut-off 4 had sensitivity 0.90 and specificity 0.58; the cut-off 5 had
sensitivity 0.84 and specificity 0.70; and the cut-off 6 had sensitivity 0.76 and specificity 0.86. The
accuracy for bipolar II disorders was sufficient but not excellent: the cut-off 4 had sensitivity 0.80
and specificity 0.45; the cut-off 5 had sensitivity 0.70 and specificity 0.55; and the cut-off 6 had
sensitivity 0.55 and specificity 0.65.
Conclusion: Our results seem to indicate a good accuracy of MDQ, and confirm the results of
recent surveys conducted in the USA. Moreover the instrument needs to be validated in other
settings (e.g. in general practice).
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Bipolar disorders are recurring psychiatric conditions,
often of a chronic nature and highly invalidating. This
type of disorder is not always correctly diagnosed, thus
delaying the administration of an efficient means of treat-
ment [1].
The difficulties encountered in correctly recognising bipo-
lar disorders are possibly greater in epidemiological stud-
ies or for screening before psychiatric evaluation in
medical settings where clinical interviews tend to be sub-
stituted by the use of a standardised rating tool; in this
instance the interviewer (not a specialised psychiatrist) is
unable to identify aspects which are fundamental for a
correct diagnosis of the illness.
On the basis of the above considerations, and in view also
of the high cost of involving specialised psychiatrists in
studies of an epidemiological nature (at times carrying
out a semi-structured interview), international research
has focused on the compiling of screening questionnaires
to be used in epidemiological investigations of bipolar
disorders, to be performed according to a "2nd phase"
design.
The aim of the present study, carried out in a sample of
psychiatric patients attending a mental health clinic with
an elevated proportion of patients coming from the gen-
eral hospital for a psychiatric evaluation, was to obtain a
preliminary standardisation of the Italian version of one
of the most recently prepared screening tools, the Mood
Disorder Questionnaire (MDQ) [2-4]. The "Gold Stand-
ard" is represented by a psychiatric diagnosis carried out
by means of a semi-structured interview.
Methods
Study design
The study design consisted in the evaluation of the accu-
racy of the Italian version of the Mood Disorder Question-
naire (MDQ) [2-4], using the Structured Clinical
Interview for DSM-IV Axis I Disorders (SCID) [5] as a
Gold Standard. The SCID was held with all subjects phy-
sicians working in the field of psychiatry for at least three
years, all of whom had undergone specific training for the
use of the SCID.
Immediately prior to the interview all subjects had filled
in the Italian version of the MDQ. Written informed con-
sent was obtained from all study participants. The ques-
tionnaire had been translated into Italian before the start
of the research project, had been back-translated into Eng-
lish and approval had been obtained from one of the
authors of the original version.
Table 1 illustrates the characteristics of the sample: a con-
secutive series of 154 subjects (61 males, mean age 35.9 ±
12.3 years; 93 females, mean age 38.4 ± 12.5 years)
referred to the Division of Psychiatry of the University of
Cagliari (Italy) either: seeking psychiatric care or counsel-
ling, coming from the general hospital of the University of
Cagliari for a psychiatric evaluation, or applying for legal
certification of their mental capacities (for driving and/or
gun licences, etc).
Instruments
SCID: the Structured Clinical Interview for DSM-IV Disor-
ders of Axis I [5] is a semi-structured interview aimed at
formulating the main diagnoses covered by Axis I of DSM-
IV [6].
MDQ: the Mood Disorder Questionnaire [2-4] is a self-
administered single-page paper and pencil inventory
made up of 13 yes/no items derived from both the DSM-
IV criteria [6] and clinical experience, which assess the
macro-area of mood, a lifetime history of a manic or
hypomanic syndrome, placing particular emphasis on a
marked subjective variation in the dimensions of irritabil-
ity, activity, sociability, sleep, libido, thoughts, attention,
energy, behaviour, etc.
We evaluated the discriminatory capacity (patients with a
diagnosis of Bipolar Disorder I or II or Schizoaffective Dis-
order Bipolar type versus patients with other psychiatric
diagnoses or with no psychiatric diagnosis, according to
the findings of the SCID) of all 13 items contemplated in
the MDQ.
The accuracy of the MDQ questionnaire was calculated in
terms of sensitivity and specificity for each theoretically
possible cut-off point (number of positive answers). Over-
all performance of the questionnaire was graphically
assessed by means of the Relative Operating Characteristic
Analysis [7]. The specific accuracy for detecting bipolar II
disorders was calculated at best performing cut-off points
4, 5 and 6.
Results
Table 2 shows the psychiatric diagnoses in Axis I formu-
lated on the basis of the SCID; out of all subjects
Table 1: Characteristics of the sample.
Sample N Mean age ± SD (years)
Males 61 35.9 ± 12.3
Females 93 38.4 ± 12.5
Total 154 37.2 ± 12.4Page 2 of 5
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nosis of bipolar or schizoaffective bipolar type disorders,
5 of these (9.8%) were schizoaffective bipolar type, 26
(51.0%) were bipolar I and 20 (39.2 %) were bipolar II;
63 (40.9%) were diagnosed as having at least one psychi-
atric disorder in Axis I (other than bipolar or schizoaffec-
tive bipolar type), whilst 40 (25.9%) were unaffected by
any type of psychiatric disorder. Table 3 (See Figure
Table 3Figure 1
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ROC analysis. The accuracy for bipolar II disorders was: at
the cut-off 4 sensitivity 0.80 and specificity 0.45; at the
cut-off 5 sensitivity 0.70 and specificity 0.55; and at the
cut-off 6 sensitivity 0.55 and specificity 0.65.
Discussion
The results of this study seem to indicate a fairly good per-
formance of the questionnaire, at least from a preliminary
point of view. The use of different cut-off points depends
on use intended for a questionnaire. For two phases inves-
tigations, in which it is of the utmost importance that
"cases" not be overlooked during screening, as all positive
cases will subsequently undergo clinical assessment, it is
necessary to reduce the "false negatives" to a bare mini-
mum. It is therefore preferable to use a very high sensitiv-
ity, even though this may prejudice the specificity. Cut-off
point 4 of MDQ (sensitivity = 0.90, specificity = 0.58)
would for example allow an accurate two-stage investiga-
tion to be carried out, whilst reducing interviews by more
than 50%. This cut-off seems to be recommended for a
screening in a psychiatric setting with a high number of
psychiatric evaluations from the general hospital as the
psychiatric unit where this study was performed. At this
cut-off for detecting bipolar II disorders is sufficient par-
ticularly concerning the good sensitivity of 0.80 and thus
the low rate of false negatives. Nevertheless the accuracy
concerning bipolar II disorders is not excellent and is nec-
essary to underline that in tertiary care, bipolar II patients
are more likely to have a cyclothymic temperament (i.e. a
baseline high instability), which makes more likely to
have some impairment during hypomania [8]. But these
patients are a minority compared to the community and
non-tertiary care patients. Bipolar II often showing
improved functioning (in non-tertiary care outpatients)
was recently reported by Benazzi [9]. MDQ may under-
diagnose bipolar II disorder because it requires moderate/
severe impairment to score positive. Thus the validation
of MDQ in the psychiatric setting does not justify the use
of this tool in other settings (i.e. in general practice or in
the community).
The MDQ has been used in the United States as part of a
nationwide telephone investigation of the general popu-
lation, according to a single phase survey. This research
study was aimed at identifying "cases" treated and quanti-
fying the impact and social cost of bipolar disorders. For a
one-stage study to be carried out in the general psychiatry
setting the ideal cut-off point could be 6 (sensitivity 0.76,
specificity 0.82). The latter is the nearest point to the 0.1
vertex of the ROC diagram. Indeed, this point represents
the ideal screener (sensitivity 1, specificity 1). On the
other hand, the area depicted by the curve beyond the
diagonal of the diagram represents the area of validity of
the screener. At this cut-off the accuracy for bipolar II dis-
orders remains sufficient (sensitivity 0.55 and specificity
0.65) for research studies but not for screening due to the
low sensitivity and, consequently, the high rate of false
negative.
It should moreover be underlined that the MDQ is a sim-
ple and easy-to-use tool. Our results seem to indicate a
good applicability of MDQ in the European clinical set-
tings, and confirm the recent survey carried out in Finland
[10].
Table 2: Psychiatric diagnoses in Axis I formulated according to findings of the SCID semi-structured interview [5].
PSYCHIATRIC DIAGNOSES IN AXIS I
Bipolar or Schizoaffective disorder At least another 1 disorder in Axis I No diagnosis Total subjects
N % N % N % N
51 33.1 63 40.9 40 25.9 154
Table 3: Performance of the MDQ by means of ROC analysis.
Cutoff 1 2 3 4 5 6 7 8 9 10 11 12 13
Sensitivity 1 1 0,96 0,90 0,84 0,76 0,67 0,61 0,55 0,43 0,31 0,22 0,10
Specificity 0,35 0,43 0,50 0,58 0,70 0,82 0,86 0,90 0,94 0,96 0,99 1 1
1-Specificity 0,65 0,57 0,5 0,42 0,3 0,18 0,14 0,1 0,06 0,04 0,01 0 0
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